Home / Treatments / Percutaneous Tibial Nerve Stimulation
Percutaneous Tibial Nerve Stimulation denials: what the review data shows
Independent reviewers have decided 51 published cases where an insurer denied Percutaneous Tibial Nerve Stimulation — and they overturned the insurer 29.4% of the time. A denial for Percutaneous Tibial Nerve Stimulation is a starting position, not a final answer.
Published decisions
51
2001–2026
Overturned
29.4%
15 denials reversed
By condition
Published outcomes when Percutaneous Tibial Nerve Stimulation was denied for these conditions.
| Condition | Decisions | Overturned |
|---|---|---|
| Overactive Bladder | 25 | 44% |
How to use this in your appeal
These are outcomes from California’s external review program — an independent physician panel that binds the insurer. Every state has an equivalent process, and internal appeals succeed even more often. Cite the outcome record for Percutaneous Tibial Nerve Stimulationwhen you appeal: reviewers routinely find that denials like yours didn’t hold up.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY
Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.